Published on in Vol 23, No 5 (2021): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27446, first published .
An eHealth Framework for Managing Pediatric Growth Disorders and Growth Hormone Therapy

An eHealth Framework for Managing Pediatric Growth Disorders and Growth Hormone Therapy

An eHealth Framework for Managing Pediatric Growth Disorders and Growth Hormone Therapy

Paul Dimitri   1 * , BSc, MBChB, PhD ;   Luis Fernandez-Luque   2 * , PhD ;   Indraneel Banerjee   3 , MD ;   Ignacio Bergadá   4 , MD ;   Luis Eduardo Calliari   5 , MD ;   Jovanna Dahlgren   6, 7 , MD ;   Antonio de Arriba   8 , PhD, MD ;   Risto Lapatto   9 , PhD, MD ;   Thomas Reinehr   10 , MD ;   Senthil Senniappan   11 , PhD, MD ;   Cécile Thomas-Teinturier   12 , MD ;   Meng-Che Tsai   13 , MD ;   Azriyanti Anuar Zaini   14 , MBBS ;   Merat Bagha   15 , MSEE ;   Ekaterina Koledova   16 , PhD, MD

1 The Academic Unit of Child Health, Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom

2 Adhera Health Inc, Palo Alto, CA, United States

3 Royal Manchester Children’s Hospital, Manchester University Hospitals Foundation Trust, Manchester, United Kingdom

4 Centro de Investigaciones Endocrinológicas “Dr. César Bergadá” (CEDIE), Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina

5 Department of Paediatrics, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil

6 Department of Pediatrics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden

7 Department of Pediatrics, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden

8 Paediatric Endocrinology, Hospital Universitario Miguel Servet, Zaragoza, Spain

9 New Children’s Hospital, University of Helsinki, and Helsinki University Hospital, Helsinki, Finland

10 Vestische Hospital for Children and Adolescents, University of Witten/Herdecke, Datteln, Germany

11 Department of Paediatric Endocrinology, Alder Hey Children's Hospital, Liverpool, United Kingdom

12 Department of Pediatric Endocrinology, Assistance Publique – Hôpitaux de Paris, Université Paris Saclay, Hôpital Bicetre, Le Kremlin Bicêtre, France

13 Department of Pediatrics, National Cheng Kung University, Tainan, Taiwan

14 Department of Pediatrics, University Malaya Medical Centre, Kuala Lumpur, Malaysia

15 Tiba Medical Inc, Beaverton, OR, United States

16 Global Medical Affairs, Cardiometabolic and Endocrinology, Merck KGaA, Darmstadt, Germany

*these authors contributed equally

Corresponding Author:

  • Paul Dimitri, BSc, MBChB, PhD
  • The Academic Unit of Child Health
  • Sheffield Children's NHS Foundation Trust
  • Damer St Building
  • Western Bank
  • Sheffield, S10 2TH
  • United Kingdom
  • Phone: 44 114 271 7118
  • Email: paul.dimitri@nhs.net